-Bloomberg TV
Keybanc Maintains Overweight on Marqeta, Raises Price Target to $12
Keybanc analyst Josh Beck maintains Marqeta (NASDAQ:MQ) with a Overweight and raises the price target from $11 to $12.
Related Posts
WuXi Biologics Announces Research Service Agreement With BioNTech On Discovering Investigational Monoclonal Antibodies For Developing Next-Generation Therapeutic Product Candidates; WuXi Biologics Will Receive A $20M Upfront Payment
WuXi Biologics ("WuXi Bio") (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that its Research Service Unit (R in CRDMO) has signed a research service
Core & Main, Planet Labs And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
India’s Reliance Jio Partnered With Qualcomm and Microsoft to Produce a 4G Enabled Laptop Priced at $184, Reuters Reported Sunday
https://www.reuters.com/technology/exclusive-indias-reliance-jio-launch-4g-enabled-low-cost-laptop-184-sources-2022-10-02/